524414 NORRIS

Norris Medicines Share Price

₹22.84
+ 1.08 (4.96%)
10 November, 2024 00:59 BSE: 524414 NSE: NORRIS ISIN: INE744C01029

Start SIP in Norris Medicines

Start SIP

Norris Medicines Performance

Day Range

  • Low 0
  • High 0
₹ 22

52 Week Range

  • Low 0
  • High 0
₹ 22
  • Open Price0
  • Previous Close0
  • Volume

Norris Medicines Chart

  • Over 1 Month + 38.01%
  • Over 3 Month + 68.19%
  • Over 6 Month + 91.13%
  • Over 1 Year + 96.05%

Norris Medicines Key Statistics

Norris Medicines Investment Rating

  • Master Rating:
  • Norris Medicines has an operating revenue of Rs. 5.41 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -19% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

    Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 111311
Operating Expenses Qtr Cr 111311
Operating Profit Qtr Cr 000001
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000001
Net Profit Qtr Cr 0000-1-1
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 68
Operating Expenses Annual Cr 67
Operating Profit Annual in Cr 01
Depreciation Cr 11
Interest Annual Cr 02
Tax Annual Cr 01
Net Profit Annual Cr -1-2
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 01
Cash from Investing Activity Annual Cr 00
Cash from Financing Annual Activity Cr 0-1
Net Cash Flow Annual Cr 0
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr -14-12
Fixed Assets Annual Cr 66
Total Non Current Assets Annual Cr 89
Total Current Assets Annual Cr 65
Total Assets Annual Cr 1414
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs -14-13
ROE Annual % 00
ROCE Annual % -155
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -311
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Norris Medicines Technicals

EMA & SMA

Current Price
₹22.84
+ 1.08 (4.96%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹19.01
  • 50 Day
  • ₹17.81
  • 100 Day
  • ₹16.57
  • 200 Day
  • ₹15.54
  • 20 Day
  • ₹18.83
  • 50 Day
  • ₹18.08
  • 100 Day
  • ₹15.72
  • 200 Day
  • ₹15.95

Norris Medicines Resistance and Support

PIVOT
₹22.84
Resistance
First Resistance 22.84
Second Resistance 22.85
Third Resistance 22.85
RSI 71.90
MFI 81.29
MACD Single Line 0.39
MACD 0.87
Support
First Support 22.83
Second Support 22.83
Third Supoort 22.82

Norris Medicines Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,053 405,300 100
Week 3,847 384,680 100
1 Month 2,091 209,118 100
6 Month 1,441 135,099 93.74

Norris Medicines Result Highlights

Norris Medicines Synopsis

BSE-Medical-Biomed/Biotech

Norris Medicines is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8.36 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2023. Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581.
Market Cap 23
Sales 5
Shares in Float 0.66
No of funds 6
Yield
Book Value 7.63
U/D Vol ratio 2.9
LTDebt / Equity
Alpha 0.28
Beta 0.38

Norris Medicines Shareholding Pattern

Owner NameSep-24Jun-24Mar-24Dec-23
Promoters 34.01%34.01%34.01%34.01%
Mutual Funds 0.01%0.01%0.01%0.01%
Financial Institutions/ Banks 0.06%0.06%0.06%0.06%
Individual Investors 20.71%20.7%20.7%20.66%
Others 45.21%45.22%45.22%45.26%

Norris Medicines Management

Name Designation
Mrs. Susmita Mahapatra Woman Director
Mr. Shaikh Amanullah Mohamed Azmathullah Director
Dr. Hiten Parikh Director
Mr. Vimal Shah Managing Director

Norris Medicines Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Norris Medicines Corporate Action

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-14 Quarterly Results
2023-12-29 Others Inter alia : 1. To Consider and approve Authorized Signatory for Bank Operations. 2. To Consider and recommend Mr. Vimal Shah as a Director of the Company subject to Members approval.
2023-11-18 A.G.M.

Norris Medicines FAQs

What is Share Price of Norris Medicines ?

Norris Medicines share price is ₹22 As on 10 November, 2024 | 00:45

What is the Market Cap of Norris Medicines ?

The Market Cap of Norris Medicines is ₹22.8 Cr As on 10 November, 2024 | 00:45

What is the P/E ratio of Norris Medicines ?

The P/E ratio of Norris Medicines is -24.3 As on 10 November, 2024 | 00:45

What is the PB ratio of Norris Medicines ?

The PB ratio of Norris Medicines is -1.7 As on 10 November, 2024 | 00:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23